BMJ
- FISHER M
Understanding the history of vaccine hesitancy and current mistrust in
healthcare.
BMJ. 2024;384:q539.
- MAJEED A
Increasing measles, mumps, and rubella (MMR) vaccine uptake in primary care.
BMJ. 2024;384:q552.
J Infect
- FATLY ZA, Betjes MGH, Dik WA, Fouchier RAM, et al
Mycophenolate mofetil hampers antibody responses to a broad range of vaccinations
in kidney transplant recipients: results from a randomized controlled study.
J Infect. 2024 Mar 1:106133. doi: 10.1016/j.jinf.2024.106133.
J Infect Dis
- LIM WW, Shuo F, Wong SS, Sullivan SG, et al
Hemagglutination inhibition antibody titers mediate influenza vaccine efficacy
against symptomatic influenza A(H1N1), A(H3N2), and B/Victoria infections.
J Infect Dis. 2024 Mar 7:jiae122. doi: 10.1093.
- COLON W, Oriol Mathieu V, Hural J, Hattingh L, et al
HIV Diagnostics and Vaccines: It Takes Two to Tango.
J Infect Dis. 2024 Mar 7:jiae113. doi: 10.1093.
- WESTERCAMP N, Osei-Tutu L, Schuerman L, Kariuki SK, et al
Could less be more? Accounting for fractional-dose regimens and different number
of vaccine doses when measuring the impact of the RTS, S/AS01E malaria vaccine.
J Infect Dis. 2024 Mar 4:jiae075. doi: 10.1093.
- CHONG EA, Kumashie KG, Chong ER, Fabrizio J, et al
Immunologic predictors of vaccine responsiveness in patients with lymphoma and
CLL.
J Infect Dis. 2024 Mar 4:jiae106. doi: 10.1093.
J Virol
- HSIEH M-S, Hsu C-W, Liao H-C, Lin C-L, et al
SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against
various SARS-CoV-2 variants in hamsters.
J Virol. 2024 Feb 1:e0154623. doi: 10.1128/jvi.01546.
- ROWE T, Davis W, Wentworth DE, Ross T, et al
Differential interferon responses to influenza A and B viruses in primary ferret
respiratory epithelial cells.
J Virol. 2024 Jan 31:e0149423. doi: 10.1128/jvi.01494.
JAMA
- HARRIS E
HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569.
MMWR Morb Mortal Wkly Rep
- MOLINE HL, Tannis A, Toepfer AP, Williams JV, et al
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory
Syncytial Virus-Associated Hospitalization Among Infants Entering Their First
Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October
2023-February 2024.
MMWR Morb Mortal Wkly Rep. 2024;73:209-214.
- OU AC, Zimmerman LA, Alexander JP Jr, Crowcroft NS, et al
Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide,
2012-2022.
MMWR Morb Mortal Wkly Rep. 2024;73:162-167.
Nat Immunol
- TRAN KA, Pernet E, Sadeghi M, Downey J, et al
BCG immunization induces CX3CR1(hi) effector memory T cells to provide
cross-protection via IFN-gamma-mediated trained immunity.
Nat Immunol. 2024;25:418-431.
Nat Med
- XU H, Zou K, Dent J, Wiens KE, et al
Enhanced cholera surveillance to improve vaccination campaign efficiency.
Nat Med. 2024 Mar 5. doi: 10.1038/s41591-024-02852.
Pediatr Infect Dis J
- PLOTKIN SA
We Need a New Mumps Vaccine.
Pediatr Infect Dis J. 2024;43:350.
- KORBAL P, Wysocki J, Jackowska T, Kline M, et al
Phase 3 Safety and Immunogenicity Study of a Three-dose Series of Twenty-valent
Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers.
Pediatr Infect Dis J. 2024 Mar 8. doi: 10.1097/INF.0000000000004300.
PLoS One
- SCHRIJVERS-GONLAG M, Skarpe C, Julkunen-Tiitto R, Poleo ABS, et al
Phenolic concentrations and carbon/nitrogen ratio in annual shoots of bilberry
(Vaccinium myrtillus) after simulated herbivory.
PLoS One. 2024;19:e0298229.
- KECHAGIAS KS, Laleye JD, Drmota J, Geropoulos G, et al
Minimal change disease following COVID-19 vaccination: A systematic review.
PLoS One. 2024;19:e0297568.
- WILLIAMS SV, Akande T, Abbas K
Systematic review of social determinants of childhood immunisation in low- and
middle-income countries and equity impact analysis of childhood vaccination
coverage in Nigeria.
PLoS One. 2024;19:e0297326.
- MALITA MA, Manolescu LSC, Perieanu VS, Babiuc I, et al
COVID-19 and flu vaccination in Romania, post pandemic lessons in healthcare
workers and general population.
PLoS One. 2024;19:e0299568.
- AGIMAS MC, Alemayehu MA, Derseh NM, Aragaw FM, et al
Correction: Spatial pattern and associated factors of timely vaccination in
Ethiopia using EDHS-2016 data: A multilevel and spatial analysis.
PLoS One. 2024;19:e0300482.
- ZHANG X, Han X, Chen B, Fu X, et al
Influence of nutritional supplements on antibody levels in pregnant women
vaccinated with inactivated SARS-CoV-2 vaccines.
PLoS One. 2024;19:e0289255.
- GIANNOUCHOS TV, Hair NL, Olatosi B, Li X, et al
Waning effectiveness of mRNA COVID-19 vaccines against inpatient and emergency
department encounters.
PLoS One. 2024;19:e0300198.
- TANNER AE, Hall MA, Aguilar-Palma SK, Mann-Jackson L, et al
Understanding uptake of COVID-19 testing, vaccination, and boosters among
Spanish-speaking Latines in the United States: Qualitative insights from Spanish
speakers and key informants.
PLoS One. 2024;19:e0296812.
- SENJAM SS, Manna S, Goel G, Balhara YPS, et al
Vaccination coverage against COVID-19 among rural population in Haryana, India: A
cross-sectional study.
PLoS One. 2024;19:e0299564.
Science
- COHEN J
Skin side effects stymie advance of HIV vaccine.
Science. 2024;383:1044.
- TRIUNFOL M
Brazil is hoping and waiting for a new vaccine as dengue rages.
Science. 2024;383:1042-1043.
Vaccine
- DUAN X, Zhang L, Ding L, Zhang C, et al
Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease
profile of post-vaccination infection.
Vaccine. 2024 Mar 2:S0264-410X(24)00172-5. doi: 10.1016/j.vaccine.2024.
- ZAMAN K, Schuind AE, Adjei S, Antony K, et al
Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in
girls 9-14 years of age: Interim analysis from a phase 3 clinical trial.
Vaccine. 2024 Mar 1:S0264-410X(24)00251-2. doi: 10.1016/j.vaccine.2024.
- YASHAR-GERSHMAN SG, Rosenberg AT, Sawhney M, Fernanda Machicao M, et al
Developing a novel screening tool to address pediatric COVID-19 vaccine hesitancy
at point of care.
Vaccine. 2024 Mar 1:S0264-410X(24)00228-7. doi: 10.1016/j.vaccine.2024.
- KOHLI M, Maschio M, Lee A, Igarashi A, et al
Projections of the incidence of COVID-19 in Japan and the potential impact of a
Fall 2023 COVID-19 vaccine.
Vaccine. 2024 Feb 29:S0264-410X(24)00117-8. doi: 10.1016/j.vaccine.2024.
- CHATHAM-STEPHENS K, Carter RJ, Duggar C, Woodworth KR, et al
An overview of the COVID-19 pediatric vaccine program - The U.S. experience
vaccinating children ages 6 months through 17 years.
Vaccine. 2024 Feb 29:S0264-410X(24)00166-X. doi: 10.1016/j.vaccine.2024.
- BEAVIS AC, Dienger-Stambaugh K, Briggs K, Chen Z, et al
A J Paramyxovirus-vectored HIV vaccine induces humoral and cellular responses in
mice.
Vaccine. 2024 Mar 4:S0264-410X(24)00227-5. doi: 10.1016/j.vaccine.2024.
- MARQUES RF, Gimenez AM, Caballero O, Simpson A, et al
Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria
vaccine using Poly-ICLC (Hiltonol(R)) as adjuvant.
Vaccine. 2024 Mar 5:S0264-410X(24)00229-9. doi: 10.1016/j.vaccine.2024.
- RAETHKE M, van Hunsel F, Luxi N, Lieber T, et al
Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country
cohort event monitoring study.
Vaccine. 2024 Mar 6:S0264-410X(24)00273-1. doi: 10.1016/j.vaccine.2024.
- CHEN D, Cowling BJ, Ainslie KEC, Lin Y, et al
Association of COVID-19 vaccination with duration of hospitalization in older
adults in Hong Kong.
Vaccine. 2024 Mar 5:S0264-410X(24)00252-4. doi: 10.1016/j.vaccine.2024.
- WONG WHS, Leung DL, Yip KM, So HK, et al
Effectiveness of inactivated COVID-19 vaccine CoronaVac in children aged less
than 3 years old during Omicron wave in Hong Kong.
Vaccine. 2024 Mar 6:S0264-410X(24)00226-3. doi: 10.1016/j.vaccine.2024.
- KARRAS J, Harrison M, Steffens M, Abdi I, et al
"COVID is a huge jigsaw puzzle that I am trying to make sense of myself":
Exploring the perceptions towards the COVID-19 vaccine communication strategy in
Australia amongst unvaccinated Australian adults.
Vaccine. 2024 Mar 6:S0264-410X(24)00276-7. doi: 10.1016/j.vaccine.2024.
- GHASEMIFAR S, Chabak O, Piri-Gharaghie T, Doosti A, et al
PIRES2-EGFP/CTB-UreI vaccination activated a mixed Th1/Th2/Th17 immune system
defense towards Helicobacter pylori infection in the BALB/c mice model.
Vaccine. 2024 Mar 7:S0264-410X(24)00209-3. doi: 10.1016/j.vaccine.2024.
- MENG L, Harris L, Shaw L, Lymon H, et al
Social and demographic factors associated with receipt of a COVID-19 vaccine
initial booster dose and with interval between primary series completion and
initial booster dose uptake among persons aged >/= 12 years, United States, August
2021-October 2
Vaccine. 2024 Mar 6:S0264-410X(24)00271-8. doi: 10.1016/j.vaccine.2024.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016